StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of Lipocine stock opened at $4.24 on Tuesday. Lipocine has a 1 year low of $3.30 and a […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Monday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance NASDAQ:LPCN opened at $4.42 on Monday. Lipocine has a 1 year low of $3.30 and a 1 year high of $14.28. The […]
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report report published on Monday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Down 2.9 % NASDAQ:LPCN opened at $4.29 on Monday. The firm has a market cap of $22.31 million, a P/E ratio […]
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report issued on Saturday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of LPCN stock opened at $4.76 on Friday. Lipocine has a 52-week low of $3.30 and a 52-week high of $14.53. […]
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note published on Friday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of NASDAQ:LPCN opened at $4.85 on Friday. The firm has a market capitalization of $25.22 million, a PE ratio of […]